Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia

Gynecologic Oncology

Volumn 103, Issue 3, 2006, Pages 1017-1022

  Parham, Groesbeck P ^a,b   Sahasrabuddhe, Vikrant V ^c   Mwanahamuntu, Mulindi H ^d   Shepherd, Bryan E ^c   Hicks, Michael L ^e   Stringer, Elizabeth M ^a,b   Vermund, Sten H ^b,c  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY TEACHING HOSPITAL   (Zambia)

^e Pontiac Cancer Institute   (United States)

Author keywords

Cervical Cancer; Cytology; HIV; Screening; Zambia

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVAL; CYTOPATHOLOGY; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL SERVICE; MONOLAYER CULTURE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SAMPLE SIZE; SCREENING TEST; SEROPREVALENCE; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TISSUE SECTION; UNIVARIATE ANALYSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS ETIOLOGY; WART VIRUS; ZAMBIA;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH; ZAMBIA;

EID: 33751551138     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.06.015     Document Type: Article

References (47)

1. GLOBOCAN: Cancer incidence and mortality worldwide database. Lyon, France: International Agency for Research on Cancer (http://www-dep.iarc.fr/globocan/database.htm).
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
3. Drain P.K., Holmes K.K., Hughes J.P., and Koutsky L.A. Determinants of cervical cancer rates in developing countries. Int. J. Cancer 100 2 (2002) 199-205
4. Sankaranarayanan R., Budukh A.M., and Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull. World Health Organ. 79 10 (2001) 954-962
5. Cervical cancer. National Institutes of Health Consensus Development Conference Statement: April 1-3, 1996 (http://consensus.nih.gov/1996/1996CervicalCancer102html).
6. Report of the Global HIV/AIDS Epidemic, 2005, UNAIDS. Available online (http://www.unaids.org).
7. HIV/AIDS in Zambia: THE Epidemic and its impact: AVERT Web publication (http://www.avert.org/aids-zambia.htm).
8. The President's Emergency Plan for AIDS Relief: Five-Year Strategy. USAID: PEPFAR (http://www.state.gov/documents/organization/48746.pdf).
9. The Global Fund for AIDS, Tuberculosis and Malaria Online (http://www.theglobalfund.org/en/about/publications/brochure/).
10. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., and Wright Jr. T.C. Human papillomavirus infection in women infected with the human immunodeficiency virus. N. Engl. J. Med. 337 (1997) 1343-1349
11. Vermund S.H., Kelley K.F., Klein R.S., Feingold A.R., Schreiber K., Munk G., et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am. J. Obstet. Gynecol. 165 2 (1991) 392-400
12. Mandelblatt J.S., Kanetsky P., Eggert L., and Gold K. Is HIV infection a cofactor for cervical squamous cell neoplasia?. Cancer Epidemiol., Biomarkers Prev. 8 1 (1999) 97-106
13. Tate D.R., and Anderson R.J. Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis. Am. J. Obstet. Gynecol. 186 (2002) 880-882
14. World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva, Switzerland (http://www.who.int/reproductive-health/publications/rhr_01_10_mngt_stis ).
15. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al., Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 16 (2002) 2114-2119
16. Roche Linear Array PCR Information material. Available online (http://www.roche-diagnostics.cz/download/mol/virologicke/hpv/LINEAR%20A RRAY%20HP V%20Genotypizacni%20Test.pdf).
17. McIndole W.A., McLean M.R., Jones R.W., and Mullins P.R. The invasive potential of carcinoma in situ of the cervix. Obstet. Gynecol. 64 (1984) 451-458
18. Ag O. Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Oncol. 12 (1993) 186-192
19. Ho G.Y.F., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338 (1998) 423-428
20. Ferenczy A., Coutlee F., Franco E., and Hankins C. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ 169 5 (2003) 431-434
21. Fruchter R.G., Maiman M., Arrastia C.D., Matthews R., Gates E.J., and Holcomb K. Is HIV infection a risk factor for advanced cervical cancer?. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 18 (1998) 241-245
22. Heard I., Palefsky J.M., and Kazatchkine M.D. The impact of HIV antiviral therapy on human papillomavirus [HPV] infections and HPV-related diseases. Antivir. Ther. 9 1 (2004) 13-22
23. Poli G., Bressler P., Kinter A., Duh E., Timmer W.C., et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor a by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172 (1990) 151-158
24. Massad L.S., Ahdieh L., Benning L., Minkoff H., Greenblatt R.M., Watts H., et al. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study. J. Acquired Immune Defic. Syndr. 96 (2001) 403-409
25. Chirenje Z.M., Loeb L., Mwale M., et al. Association of cervical SIL and HIV-1 infection among Zimbabwean women in an HIV/STI prevention study. Int. J. STD AIDS 13 (2002) 765-768
26. Womack S.D., Chirenje Z.M., Blumentgahl P.D., McGrath J.A., and Chipato T. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int. J. Cancer 85 (2000) 206-210
27. Temmerman M., Tyndall M.W., Kidula N., Claeys P., Muchiri L., and Quint W. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of HIV-1 infection. Int. J. Gynecol. Obstet. 65 (1999) 171-181
28. Gichangi P., De Vuyst H., Estambale B., Rogo K., Bwayo J., and Temmerman M. HIV and cervical cancer in Kenya. Int. J. Gynecol. Obstet. 76 (2002) 55-63
29. Hawes S.E., Critchlow C.W., Niang M.A., Diouf M.B., Diop A., Toure P., et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J. Infect. Dis. 188 (2003) 555-563
30. Hawes S.E., Critchlow C.W., Sow P.S., Toure P., N'Doye I., Diop A., et al. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 [HIV-1] and HIV-2. J. Natl. Cancer Inst. 98 2 (2006) 100-109
31. Miotti P.G., Dallabetta G.A., Daniel R.W., et al. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi. J. Infect. Dis. 173 (1996) 714717
32. Folkers G. Increased risk of cervical abnormalities among HIV-infected African women. NIAID AIDS Agenda 9 (1996) 11
33. Leroy V., Ladner J., Clerq A.D., Meheus A., Nyiraziraje M., et al. Cervical dysplasia and HIV type-1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. Sex. Transm. Infect. 75 (1999) 103-106
34. Kapiga S.H., Msamanga G.I., Spiegelman D., Mwakyoma H., Fawzi W.W., and Hunter D.J. Risk factors for cervical squamous intraepithelial lesions among HIV-1 seropositive women in Dar es Salaam, Tanzania. Int. J. Gynecol. Obstet. 67 (1999) 87-94
35. Laga M., Icenogle J.P., Marsella R., et al. Genital papillomavirus infection and cervical dysplasia-opportunistic complications of HIV infection. Int. J. Cancer 50 (1992) 45-48
36. Marais D.J., Vardas E., Ramjee G., Allan B., Kay P., Rose R.C., et al. The impact of human immunodeficiency virus type 1 status on human papillomavirus [HPV] prevalence and HPV antibodies in serum and cervical secretions. J. Infect. Dis. 182 4 (2000) 1239-1242 [electronic publication 2000 Sep. 8]
37. Denny L., Kuhn L., De Souza M., Pollack A.E., Dupree W., and Wright Jr. T.C. Screen- and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 294 17 (2005) 2173-2181
38. Abulafia O., Pezzullo J.C., and Sherer D.M. Performance of the ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol. Oncol. 90 1 (2003) 137-144
39. Biscotti C., Dawson A., Dziura B., Galup L., Darragh T., Rahemtulla A., et al. Assisted primary screening using the automated ThinPrep imaging system. Am. J. Clin. Pathol. 123 2 (2005) 281-287
40. Dawson A.E. The changing face of cervical screening. Challenges for the future. Diagn. Cytopathol. 33 2 (2005) 63-64
41. Fahey M.T., Irwig L., and Macaskill P. Meta-analysis of Pap test accuracy. Am. J. Epidemiol. 141 7 (1995 (Apr. 1)) 680-689
42. Nanda K., McCrory D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D., et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann. Intern. Med. 132 10 (2000 (May 16)) 810-819
43. Massad L.S., Schneider M.F., Watts D.H., Strickler H.D., Melnick S., Palefsky J., et al. HPV testing for triage of HIV-infected women with Papanicolaou smears read as atypical squamous cells of uncertain significance. J. Women's Health (Larchmt.) 13 2 (2004) 147-153
44. Goldie S.J., Freedberg K.A., Weinstein M.C., Wright T.C., and Kuntz K.M. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. Am. J. Med. 111 2 (2001 (Aug.)) 140-149
45. Goldie S.J., Weinstein M.C., Kuntz K.M., and Freedberg K.A. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann. Intern. Med. 130 2 (1999) 97-107
46. Stany M., Rose G., and Zahn C. Special situations: abnormal cervical cytology in immunocompromised patients. Clin. Obstet. Gynecol. 48 (2005) 186-192
47. Harrell Jr. F.E., Lee K.L., Matchar D.B., and Reichert T.A. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat. Rep. 69 (1985) 1071-1077